(b).

	(n = 6)	Sodium (mmol/L)	Potassium (mmol/L)	Chloride (mmol/L)	Urea (mmol/L)	Creatinine (μmol/L)
Control	Female	148.6 ± 0.4	39.6 ± 1.6	106.4 ± 2.3	7.9 ± 0.1	31.8 ± 0.6
	Male	142.5 ± 1.5	54.8 ± 2.2	111.7 ± 2.1	7.2 ± 1.0	32 ± 2.9
Vehicle	Female	143.2 ± 1.2	39.8 ± 0.8	109.4 ± 1.6	7.2 ± 1.2	32.8 ± 1.1
	Male	145.2 ± 1.7	59.8 ± 2.02	115.7 ± 1.6	7.7 ± 1.1	33.2 ± 1.8
ZER (100 mg/kg)	Female	151.5 ± 0.5	41.7 ± 0.3	108.2 ± 0.7	8.4 ± 1.0	35.6 ± 0.8
	Male	144.7 ± 2.1	57.3 ± 1.9	112.1 ± 2.7	7.3 ± 2.3	35.8 ± 3.1
ZER (200 mg/kg)	Female	153.2 ± 0.3	44.4 ± 1.6	111.06 ± 2.1	8.8 ± 2.2	37.2 ± 3.2
	Male	145.8 ± 1.9	56.4 ± 3.3	117.05 ± 3.1	7.9 ± 3.5	35.6 ± 2.7
NLC (100 mg/kg)	Female	152 ± 0.9	43.7 ± 0.5	107.7 ± 0.6	7.35 ± 0.1	33.53 ± 0.8
	Male	142.6 ± 3.0	56.2 ± 3.3	107.8 ± 0.3	6.3 ± 1.7	31.3 ± 1.5
NLC (200 mg/kg)	Female	145.4 ± 0.6	43.2 ± 0.4	106.7 ± 0.6	6.4 ± 0.4	34.6 ± 1.5
	Male	141.1 ± 1.0	550.4 ± 1.4	108.5 ± 1.3	6.3 ± 1.1	36.7 ± 2.5
ZER-NLC (100 mg/kg)	Female	146.4 ± 0.8	44.5 ± 0.4	106 ± 0.2	6.6 ± 0.3	33.8 ± 0.1
	Male	140.2 ± 3.0	55.2 ± 2.5	107.4 ± 3.1	6.9 ± 0.4	34.6 ± 2.5
ZER-NLC (200 mg/kg)	Female	146.9 ± 0.7	47 ± 0.2	107.8 ± 0.3	6.5 ± 0.3	36 ± 0.2
	Male	141.9 ± 2.1	56.8 ± 3.8	112.3 ± 2.5	7.8 ± 1.2	29.7 ± 2.6

Treatment was performed for 14 days. Values are mean ± SD (n = 6) and have been analyzed using post hoc comparison test one way ANOVA. Data revealed nonsignificant (P > 0.05) difference in liver function test after 14 days in all treated groups when compared to that of untreated control group.